Doctronic Raises $40M Series B to Scale AI-Native Telehealth Platform

Pressure shows up early in healthcare. Not the dramatic kind. The quiet kind. The kind that exposes whether what you built can actually hold weight when real people lean on it. Doctronic did not flinch. Doctronic, the New York City based AI-driven telehealth company, secured $40M in Series B funding, led by Abstract and Lightspeed Venture Partners, with Union Square Ventures, Seven Stars, Mantis, and Tusk Ventures doubling down like they have seen this movie before and liked the ending. That brings the total raised north of $65M in under a year. Not a slow burn. More like a controlled detonation.

Co founder and Co CEO Matt Pavelle and co founder Adam Oskowitz, M.D. are not playing startup theater. One brings operator instinct, the other brings clinical reality. Together they built something that does not just talk medicine, it touches it. Over 300,000 weekly users, more than 20M consults, and an 8 figure revenue run rate say this is not a science project. It is already in circulation.

The product walks a tightrope that most would not even step onto. Free consults that actually engage, paired with $39 telehealth visits that close the loop with licensed clinicians. Then there is Utah, where Doctronic is operating inside the AI Learning Lab, renewing prescriptions with guardrails and oversight. Not hype. Not theory. A live wire running through a regulated system.

What stands out is not just the tech, it is the discipline. QHIN and TEFCA connectivity, Surescripts for medication history, First Databank for interaction checks. This is less “move fast and break things” and more “move smart and don’t break patients.” There is a difference, and the market is starting to price it in.

The takeaway for builders is simple, even if it is not easy. Speed gets attention, but structure gets funded. Doctronic stacked growth, regulatory access, and real usage before most companies would finish their deck. They did not wait for perfect clarity from the system, they found the edges where progress is allowed and pushed there.

Healthcare has always been a fortress. Doctronic did not storm it. They found a door, got it approved, and started letting people in. Now the capital follows, the users keep showing up, and the question shifts from “if” to “how far.”